trial · primary record
Placebo
Acute Respiratory Distress Syndrome
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-10-31 |
| Primary endpoint | Cumulative Incidence of Serious Adverse Events (SAEs) Through Day 30 |
| Registry ID | NCT06564207 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:28.024Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06564207
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.